Literature DB >> 19393680

New conopeptides of the D-superfamily selectively inhibiting neuronal nicotinic acetylcholine receptors.

S Kauferstein1, Y Kendel, A Nicke, F I V Coronas, L D Possani, P Favreau, I Krizaj, C Wunder, G Kauert, D Mebs.   

Abstract

The venom of cone snails (Conus spp.) is a rich source of peptides exhibiting a wide variety of biological activities. Several of these conopeptides are neuronal nicotinic acetylcholine receptor (nAChR) antagonists and belong to the A-, M-, S-, C and the recently described D-superfamily (alphaD-conopeptides). Here we describe the discovery and characterization of two alphaD-conopeptides isolated from the venom of Conus mustelinus and Conus capitaneus. Their primary structure was determined by Edman degradation, MS/MS analysis and by a PCR based approach. These peptides show close structural homology to the alphaD-VxXIIA, -B and -C conopeptides from the venom of Conus vexillum and are dimers (about 11kDa) of similar or identical peptides with 49 amino acid residues and a characteristic arrangement of ten conserved cysteine residues. These novel types of conopeptides specifically block neuronal nAChRs of the alpha7, alpha3beta2 and alpha4beta2 subtypes in nanomolar concentrations. Due to their high affinity, these new ligands may provide a tool to decipher the localisation and function of the various neuronal nAChRs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393680     DOI: 10.1016/j.toxicon.2009.04.016

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  9 in total

1.  Carboxylator: incorporating solvent-accessible surface area for identifying protein carboxylation sites.

Authors:  Cheng-Tsung Lu; Shu-An Chen; Neil Arvin Bretaña; Tzu-Hsiu Cheng; Tzong-Yi Lee
Journal:  J Comput Aided Mol Des       Date:  2011-10-22       Impact factor: 3.686

2.  αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.

Authors:  Sean B Christensen; Pradip K Bandyopadhyay; Baldomero M Olivera; J Michael McIntosh
Journal:  Biochem Pharmacol       Date:  2015-06-11       Impact factor: 5.858

Review 3.  Conotoxins that confer therapeutic possibilities.

Authors:  Magbubah Essack; Vladimir B Bajic; John A C Archer
Journal:  Mar Drugs       Date:  2012-06-04       Impact factor: 6.085

4.  Pathogen-inspired drug delivery to the central nervous system.

Authors:  Rebecca L McCall; Joseph Cacaccio; Eileen Wrabel; Mary E Schwartz; Timothy P Coleman; Rachael W Sirianni
Journal:  Tissue Barriers       Date:  2014-08-08

5.  Effect of Methionine Oxidation and Substitution of α-Conotoxin TxID on α3β4 Nicotinic Acetylcholine Receptor.

Authors:  Jie Ren; Rui Li; Jiong Ning; Xiaopeng Zhu; Dongting Zhangsun; Yong Wu; Sulan Luo
Journal:  Mar Drugs       Date:  2018-06-20       Impact factor: 5.118

6.  αD-Conotoxins in Species of the Eastern Pacific: The Case of Conus princeps from Mexico.

Authors:  Arisaí C Hernández-Sámano; Andrés Falcón; Fernando Zamudio; César V F Batista; Jesús Emilio Michel-Morfín; Víctor Landa-Jaime; Estuardo López-Vera; Michael C Jeziorski; Manuel B Aguilar
Journal:  Toxins (Basel)       Date:  2019-07-12       Impact factor: 4.546

7.  A Novel Dimeric Conotoxin, FrXXA, from the Vermivorous Cone Snail Conus fergusoni, of the Eastern Pacific, Inhibits Nicotinic Acetylcholine Receptors.

Authors:  Ximena C Rodriguez-Ruiz; Manuel B Aguilar; Mónica A Ortíz-Arellano; Helena Safavi-Hemami; Estuardo López-Vera
Journal:  Toxins (Basel)       Date:  2022-07-26       Impact factor: 5.075

8.  A novel inhibitor of α9α10 nicotinic acetylcholine receptors from Conus vexillum delineates a new conotoxin superfamily.

Authors:  Sulan Luo; Sean Christensen; Dongting Zhangsun; Yong Wu; Yuanyan Hu; Xiaopeng Zhu; Sandeep Chhabra; Raymond S Norton; J Michael McIntosh
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

Review 9.  Discovery Methodology of Novel Conotoxins from Conus Species.

Authors:  Ying Fu; Cheng Li; Shuai Dong; Yong Wu; Dongting Zhangsun; Sulan Luo
Journal:  Mar Drugs       Date:  2018-10-30       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.